Pilot Study of Redirected Haploidentical Natural Killer Cell Infusions for B-Lineage Acute Lymphoblastic Leukemia
Stopped Suspended for an interim review of (CAR) CD19 research strategy for the treatment of CD19 positive ALL.
Conditions
- B-cell Acute Lymphoblastic Leukemia
Interventions
- BIOLOGICAL: anti-CD19 redirected NK cells
Sponsor
National University Health System, Singapore